
Broad-Based Technical Strength Lifts Hemo Organic Ltd to 52-Week High of Rs 24.42
2026-07-14 09:45:49Surging to a fresh 52-week high of Rs 24.42 on 14 Jul 2026, Hemo Organic Ltd has demonstrated remarkable price momentum, outperforming its sector by 4.99% in a single session and extending gains over two consecutive days for a total return of 10.2%. This rally comes despite a broadly negative market backdrop, underscoring the stock’s technical resilience.
Read full news article
Broad-Based Technical Strength Lifts Hemo Organic Ltd to 52-Week High of Rs 23.26
2026-07-13 09:54:48From a 52-week low of Rs 8.08 to a fresh high of Rs 23.26 on 13 Jul 2026, Hemo Organic Ltd has surged an impressive 144% over the past year, significantly outpacing the Sensex’s decline of 6.4%. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum.
Read full news articleAre Hemo Organic Ltd latest results good or bad?
2026-06-03 19:12:51Hemo Organic Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹0.93 crores, marking a return to revenue generation after three consecutive quarters of zero sales. However, this figure represents a substantial year-on-year decline of 61.41% from the previous year, indicating a severe contraction in business activity. The company faced a net loss of ₹0.51 crores, a stark contrast to the profit of ₹0.37 crores reported in the same quarter last year. This loss was accompanied by an operating margin of -31.18%, a notable decline from the positive margin of 5.81% achieved in Q4 FY25. The widening losses and negative margins underscore ongoing operational inefficiencies and challenges in sustaining profitability. Hemo Organic's balance sheet shows a negative book value of ₹-0.44 per share, reflecting complete equity erosion and raising conce...
Read full news article
Hemo Organic Q4 FY26: Steep Losses Mount as Revenue Collapses 61% - Survival Questions Intensify
2026-06-02 18:36:32Hemo Organic Ltd., a micro-cap trading and distribution company with a market capitalisation of just ₹7.00 crores, reported deeply troubling results for Q4 FY26 that underscore mounting existential challenges. The company posted a net loss of ₹0.51 crores in the March 2026 quarter, a dramatic reversal from a profit of ₹0.37 crores in the year-ago period. Revenue collapsed by 61.41% year-on-year to just ₹0.93 crores, whilst the company's balance sheet remains mired in negative net worth territory at ₹-0.15 crores.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Jul-2026 | Source : BSESubmission of Newspaper Advertisement of extract of Un-audited financials results for the quarter ended on 30th June 2026
Outcome Of The Board Meeting Held Today I.E. Wednesday 15Th July 2026
15-Jul-2026 | Source : BSESubmission of Un-audited financial Results of the company for the quarter ended as on 30th June 2026 along with Limited Review Report.
Submission Of Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026
15-Jul-2026 | Source : BSESubmission of Un-audited financial results along with limited review report for the quarter ended on 30th June 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






